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Hyperactivation of retina by light in mice leads to
photoreceptor cell death mediated by VEGF and retinal
pigment epithelium permeability
M Cachafeiro1,6, A-P Bemelmans*,1,2,6,7, M Samardzija3, T Afanasieva4, J-A Pournaras5, C Grimm3, C Kostic1, S Philippe1, A Wenzel3
and Y Arsenijevic*,1
Light toxicity is suspected to enhance certain retinal degenerative processes such as age-related macular degeneration. Death
of photoreceptors can be induced by their exposure to the visible light, and although cellular processes within photoreceptors
have been characterized extensively, the role of the retinal pigment epithelium (RPE) in this model is less well understood.
We demonstrate that exposition to intense light causes the immediate breakdown of the outer blood–retinal barrier (BRB). In a
molecular level, we observed the slackening of adherens junctions tying up the RPE and massive leakage of albumin into the
neural retina. Retinal pigment epithelial cells normally secrete vascular endothelial growth factor (VEGF) at their basolateral side;
light damage in contrast leads to VEGF increase on the apical side – that is, in the neuroretina. Blocking VEGF, by means of
lentiviral gene transfer to express an anti-VEGF antibody in RPE cells, inhibits outer BRB breakdown and retinal degeneration,
as illustrated by functional, behavioral and morphometric analysis. Our data show that exposure to high levels of visible light
induces hyperpermeability of the RPE, likely involving VEGF signaling. The resulting retinal edema contributes to irreversible
damage to photoreceptors. These data suggest that anti-VEGF compounds are of therapeutic interest when the outer BRB is
altered by retinal stresses.
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Age-related macular degeneration (AMD), a main reason for
visual impairment in the elderly,1 is linked to pathological
changes involving the retinal pigment epithelium (RPE),
a mono-stratified cell layer with multiple functions in relation
to photoreceptor physiology. The RPE constitutes the outer
blood–retinal barrier (BRB), controls fluid and metabolic
exchange between the retina and the choriocapillaris, and
participate in several functions linked to photoreceptor
physiology. In addition, RPE cells release factors controlling
neuronal survival as well as angiogenesis, such as pigment
epithelium-derived factor (PEDF), which promote photore-
ceptor survival and have anti-angiogenic action on the
choriocapillaris.2,3 The RPE secretes PEDF at the apical side
– that is, towards the neural retina – and, in contrast,
the angiogenic factor vascular endothelial growth factor
(VEGF) is secreted at the basolateral side to maintain the
fenestration of the choriocapillaris.4–6 As a consequence,
unbalanced expression of PEDF and VEGF appears to be
involved in major human pathologies such as choroidal
neovascularization (CNV) in AMD7 or diabetic retinopathy.8
Anti-VEGF treatments have thus become the therapeutic
option of choice for the management of the wet-form of AMD
involving CNV.
In contrast to in vitro data,9,10 few studies focused on RPE
cell alteration after in vivo stress. Genetic studies revealed
important mechanisms involved in the process of RPE
alteration and photoreceptor death, such as complement
factor H loss of function or ApolipoproteinE4; however, the
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mechanisms initiating deleterious effects of these gene
variants are unknown.11 Moreover, the role of environmental
detrimental stimuli is poorly understood and is mainly based
on hypotheses generated from human retina samples
(reviewed by Bird12). On the other hand, among environ-
mental factors that may impair photoreceptor survival, light
toxicity has been intensely investigated. Indeed, several
studies have shown that exposure to high-intensity of light
induces photoreceptor loss (light-damage model or LD) by
several mechanisms that can be specific to the LD model13
and by some other mechanisms that are common to other
inherited retinal dystrophies.14,15 Interestingly, different stu-
dies showed that after LD the retina presents some cardinal
features of AMD.16–19 For instance, LD leads to the
accumulation of reactive oxygen species and generation of
toxic metabolites such as N-retinylidene-N-retinylethanol-
amine (A2E), partially degraded proteins and lipid–protein
adducts.20 Moreover, high levels of environmental light have
been implicated in the accumulation of drusen,21 and photo-
oxidized A2E appears to activate the complement system,22
suggesting that RPE dysfunction may contribute to the
degeneration of photoreceptors occurring after LD. Interest-
ingly, a recent study shows that an acute stress caused by
chemical oxidative damage leads to RPE dysfunction and
photoreceptor stress.23 However, no direct evidence of the
role of RPE on photoreceptor death after physiological stress,
such as high-light exposure, has been provided so far.
In the present study, we aimed to determine whether the
RPE is also affected during the LD process and to evaluate the
degree of RPE involvement in the process of photoreceptor
death. We show the crucial contribution of RPE in the
induction of photoreceptor death process after LD, and that
VEGF drives outer BRB breakdown constituting an additional
mechanism of retinal fluid accumulation in these conditions.
Results
VEGF release and RPE permeability are the early events
in the light-damage model. In the LD model, and in our
experimental conditions, a 1-h exposure to 5000 lux induced
dramatic photoreceptor degeneration (Figure 1). Photoreceptor
cell death was evidenced on cresyl violet-stained sections
(Figures 1a–d). Cell death occurred through an apoptotic
mechanism leading to an increase in the nucleosome-free
fraction (Figure 1e). To decipher the role of the RPE in this
model, we studied the status of adherens- and tight-junction
proteins unifying this mono-layered epithelium and making the
outer BRB.24–28 On control flat-mounted RPE, zonula-occlu-
dens-1 (ZO-1), a protein involved in tight junction, and proteins
building adherens junctions, such as beta-catenin and N-cad-
herin, precisely delineate the contour of RPE cells, revealing
their hexagonal shape (Figures 2a and c–e). Twenty-four
hours after LD, these three markers have completely left their
locations associated with the plasma membrane and are
translocated into the cell cytoplasm (Figures 2b, d and f),
demonstrating the loss of RPE cell–cell connection integrity. To
determine whether the disruption of RPE junction markers
resulted in changes of the BRB permeability, extravascular
plasma leakage was evaluated by immunostaining of serum
albumin on retinal cryostat sections sampled at different times
after LD. In control eyes, albumin was found only in the
choriocapillaris layer and in the retinal vessels located at the
inner side of the retina (Figures 2g and h). However, albumin
staining was clearly visible in the outer segment (OS) layer and
massively spread toward the inner layers at 24, 36 and 48-h
post LD, indicating a plasma leakage originating from the outer
BRB (Figures 2i–n). Albumin leakage was only observed in the
central retina affected by LD and in the sites where the
photoreceptors were degenerating, but not in the peripheral
retina, which was preserved after light exposure. These
observations showed that after light damage, large plasmatic
proteins can pass the outer BRB, revealing that RPE cannot
maintain fluid and protein homeostasis in this circumstance
and suggest that this leakage contributes to retinal
degeneration.
Similar to blood capillaries, RPE permeability closely
depends on the availability of pro- and anti-angiogenic
factors such as VEGF and PEDF.9 To determine whether
these factors could be involved in the RPE permeability
occurring in the LD model, we quantified the expression
Figure 1 Light-induced photoreceptor degeneration by apoptosis. Balb/c mice were exposed to 5000 lux of white light during 1 h. Compared with retina unexposed to light
(a), cresyl violet staining of mice, respectively, analyzed 24, 36 and 48 h after LD (b–d) showed that LD-induced photoreceptor cell death progressed with time.
(e) Cytoplasmic-free nucleosomes in the retina were quantified using an ELISA-based cell death detection kit at the different time points indicated. One-way ANOVA (Dunnett’s
post hoc test) analysis revealed that the number of free nucleosomes released after LD were significantly higher 24, 36 and 48 h after the lesion compared with animals
unexposed to LD (Po0.001 for all time points studied). Each bar represents the mean value±S.D. (n¼ 6 per group). ONL: outer nuclear layer, INL: inner nuclear layer, scale
bar: 50mm
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levels of VEGF and PEDF at different times in the neural
retina and in the layers corresponding to the RPE/
choriocapillaris/sclera (referred below as the eye-cup).
In physiologic conditions, VEGFwas2.1-foldmore concentrated
in the eye-cup than in the neural retina; however, this ratio was
inverted 24-h post LD and seemed to slowly return to normal
at 36 and 48-h post LD (Figure 2o). Oppositely, PEDF is
normally present in the eye-cup, but its concentration is
markedly decreased after LD at the same time points
(Figure 2p). This suggests that the disruption of the outer
BRB that we observed in the LD model could be triggered by
an increase in several signals inducing a vasopermeabilty at
the apical pole of the RPE.
Activation of the VEGFR-2/Src pathway during RPE
permeability. The initiation of vascular permeability through
VEGFR-2 is Src kinase-dependent.29 To determine whether
this pathway was activated in the LD model, the amount of
phosphorylated-Src was measured using western blot. Using
an antibody specific for the phospho-Tyr416-activated form,
we observed a marked activation of Src kinase 6 h after LD in
the eye-cup and in the neural retina (Figures 3a and b).
In parallel, PEDF level showed a constant decrease from
24h to 48 h after LD (Figure 2p), probably leading to a relief
of its inhibitory action on VEGFR-2.30
To characterize whether the effectors – that is, VEGF
receptors VEGFR-1 and -2 – were altered after LD, their
Figure 2 VEGF-triggered RPE permeability is an early event in the light-damage model. Confocal analysis of tight- and adherens-junction markers performed on
flat-mounted RPE revealed that RPE permeability is an early event in the LD model. Whereas the beta-catenin expression delineates the contour of RPE cells revealing their
hexagonal shape on control unexposed to light (a), the expression of this marker was localized in the cytoplasm of RPE cells 24 h after LD (b). Similar results were observed
concerning the expression of ZO-1 and N-cadherin markers. Normally located in the contour of RPE cells on control unexposed to light (c–e), both of these markers translocate
in the RPE cell cytoplasm 24 h after LD (d–f) (n¼ 6 per group – magnification  400). Immunostaining of serum albumin, normally found in the choriocapillaris and in the
retinal vessels located at the inner side of the retina of control unexposed to light (g and h), showed pronounced extravascular albumin leakage 24 (i and j), 36 (k and l) and
48 h (m and n) after light exposure. After LD, albumin was prominent in the RPE and in the outer nuclear layer (ONL). Albumin positivity was also found, to a lesser extent, in
the outer plexiform layer (OPL), in the inner nuclear layer (INL), in the plexiform layer (IPL), in the ganglion cell layer (GCL) and, finally, in the inner limiting membrane (ILM),
suggesting that plasma leakage originates from the outer BRB (n¼ 6 per group—magnification  400, scale bar: 100mm in (g–n)—Green: albumin and blue: DAPI).
(o) ELISA quantification shows that VEGF level was 1.8-fold and 1.5-fold increased, respectively, 24 and 36 h after LD compared with control unexposed to light in
the neural retina (control no LD: 231.6±56.3 pg/mg protein; 24-h post LD: 423.5±79.3 pg/mg protein; 36-hour after LD: 353.8±87.7 pg/mg protein and 48-h post LD:
209.7±45.3 pg/mg protein). Contrariwise, in the eye-cup, VEGF content was significantly decreased 24, 36 and 48 h after LD compared with unexposed controls (control no
LD: 508.9±96.2 pg/mg protein; 24-h post LD: 262.9±37.3 pg/mg protein; 36-h post LD: 340.7±88.8 pg/mg protein and 48-h post LD: 262.7±132.4 pg/mg protein).
No obvious difference was observed concerning VEGF content in the whole eye, except at 48 h after LD. At this point, VEGF was 1.5-fold decreased compared with the
control. Each bar represents the mean value±S.D. (n¼ 6 per group). Statistical analyses: one-way ANOVA and Dunnett’s post hoc test: *Po0.05. (p) Western blot analysis
for PEDF in the eye-cup showed that PEDF expression was significantly reduced 24, 36 and 48 h after LD. Quantification is presented as relative expression normalized
against values of tubulin controls to adjust for protein loading. Results are expressed as mean±S.D. (n¼ 6 per group). Statistical analyses: one-way ANOVA and Tukey’s
post hoc test: *Po0.05 and **Po0.01
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expression was quantified in the eye-cup using western blot at
different time points. Between 24 and 48 h after LD, VEGFR-1
level decreased constantly (Figure 3c), whereas VEGFR2
level appeared to come back to its initial level after a decrease
in protein level of about 50% (Figure 3d). These variations
further suggested that in the LD model, the RPE permeability
was triggered by VEGF activation of a VEGFR-2-dependent
pathway at the apical side of the RPE layer (presence of
VEGFR-2 and decrease of VEGFR-1 rendering VEGF more
available).
VEGF binding on VEGFR-2 is also known to trigger the
activation of other intracellular pathways. In consequence, we
explored whether different VEGF-R pathways were perturbed
after LD or only the Src pathway was transiently activated. For
example, in the ARPE-19 cell line under oxidative stress,
VEGFR-2 activation leads to Akt phosphorylation, which in
turn provides protection to the cells.31 On the other hand,
VEGFR-2 activation can also lead to cell death, as it has been
shown in endothelial cells submitted to peroxynitrite-induced
oxidative stress.32 In this case, nitration of PI3 kinase switches
off the VEGF pro-survival pathway and activates the p38MAP
kinase pro-apoptotic pathway. We thus analyzed whether
these pathways could be activated or inhibited in the LDmodel
using western blot analysis of Akt and p38 MAP kinase in the
neural retina and in the eye-cup. Neither the protein level nor
the phosphorylation state of these proteins was modified in
the retina and the RPE during the first 48 h following LD
(Supplementary Figures S1D–O), indicating that the VEGF-
induced cell death pathway was activated neither in the
photoreceptors nor in the RPE cells. All these results strongly
suggest that the RPE permeability occurring after LD is
mediated by a VEGF increase leading to Src kinase activation
and that this mechanism indirectly induces cell death in the
photoreceptor layer knowing that some plasmatic proteins are
toxic for neurons, such as albumin.33,34
Blocking VEGF in the LD model inhibits RPE perme-
ability and extravascular leakage. To further confirm the
involvement of VEGF in the LD model, we constructed a
lentiviral vector encoding the cDNA of V65 (LV-V65) – a
single-chain antibody directed against VEGF and capable of
blocking its activity in different experimental paradigms.35,36
We inserted V65 cDNA downstream of the ubiquitous
promoter EFS (elongation factor1-alpha short promoter)
and added an IRES GFP sequence to the construct to
detect transduced cells in vivo. As control, a lentiviral vector
encoding GFP only was used (Supplementary Figure S2A).
Firstly, we assessed that the lentiviral construct was able to
express and secrete V65 from transduced cells in vitro and
in vivo (Supplementary Figures S2B–E). Secondly, to
Figure 3 RPE permeability is induced through a VEGFR-2/Src pathway. Western blot analysis showed a three-fold increase in phosphor-Tyr416-Src (P-Src) expression
6 h after LD in the eye-cup (a), as well as in the neural retina (b). The expression of VEGFR-1 decreased significantly and progressively down to 28% of basal level at 48 h after
LD (c). At 24 and 36 h after LD, VEGFR-2 expression was decreased by 45 and 35%, respectively, and seemed to return to basal level at 48 h (19% decrease, not significant – d).
Quantification results are expressed as percentage of the control group. Protein expression level was normalized against values of tubulin, GAPDH or actin controls to adjust
for protein loading. Results are expressed as mean±S.D. (n¼ 6 per group). Statistical analyses: one-way ANOVA followed by Bonferoni’s post hoc test: *Po0.05 and
**Po0.01 (no LD: control group unexposed to light)
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demonstrate that the LV-V65 vector was able to inhibit VEGF
biological activity in vivo, we used laser-induced CNV, as the
role of VEGF is widely accepted in this model37 and a marked
inhibition of neovascularization has been observed.
(Supplementary Figures S2F–J). This demonstrated that
the LV-V65 vector was able to abrogate VEGF biological
activity in vivo.
We thus tested the effect of VEGF inhibition by V65 gene
transfer in the LD model. Mice received a subretinal injection
of LV-V65 and were subjected to LD 4 weeks later. In the
control groups (no treatment prior to LD, sham- or LV-GFP-
injected), beta-catenin staining of flat-mounted RPE showed a
clear translocation toward the cytoplasm of RPE cells (Figures
4b–d). LV-V65 treatment dramatically reduced the transloca-
tion of beta-catenin. Although light staining was found in
the cytoplasm of RPE cells, the protein was retained in the
periphery of the cells to form a continuous distribution at the
interface of the cells (Figures 4e and f), which is in line with
maintenance of outer BRB integrity. In the control LD groups,
beta-catenin was translocated into the cytoplasm and was
fully absent from the cell junction region, forming a ‘negative
image’ of the normal situation.
To reveal potential BRB breakdown after LD, we studied
extravascular plasma leakage by immunostaining
of the serum albumin on cryostat sections of the retina in
the different groups. Results analyzed 10 days after
LD revealed an important plasma leakage occurring mainly
from the choriocapillaris and reaching the inner side of the
retina in the sham- and LV-GFP-injected groups. Concomi-
tantly, a significant thinning of the ONL occurred (see DAPI
staining in Figures 4k–p) compared with the non-exposed
retina (Figures 4i and j). However, in the LV-V65-treated
group, only discrete albumin leakage confined to the
outermost retina was observed, suggesting an almost
complete suppression of hyperpermeability (Figures 4q and r).
Moreover, retinal morphology appeared much better pre-
served in mice expressing V65. This collective evidence
confirmed that antagonizing VEGF in the LD model signifi-
cantly reduced RPE hyperpermeability and thus the extra-
vascular plasma leakage from the choriocapillaris toward the
neural retina.
Blocking VEGF in the LD model is neuroprotective for
photoreceptors. As we hypothesized that RPE permeability
was involved in the photoreceptor degeneration occurring
after LD, we next evaluated 10 days after LD whether VEGF
blockade by the V65 gene transfer was also beneficial to
photoreceptors by blocking RPE permeability. Indeed, at this
time, the damage induced at the level of the layer of
photoreceptors peaks in effect.13 Using the same aforemen-
tioned regimen, adult Balb/c mice were treated by a
subretinal injection of LV-V65 or a control treatment
(LV-GFP or Sham injection) 4 weeks before LD. Then,
10 days after LD, the electroretinogram response (ERG) was
quantified in scotopic conditions. Compared with unlesioned
animals, the a-wave, reflecting the activity of photoreceptors,
was almost completely abolished in sham-treated animals or
in animals that received no treatment prior to LD. In contrast,
a significant protection of the a-wave in the LV-V65 group
was observed, whereas animals that received the LV-GFP
control vector showed an intermediate response (Figures 5a
and b). Quantification of the b-wave amplitude, reflecting the
activity of second-order neurons, led to the same conclusions
(Figures 5a–c). Following ERG measurement, we estimated
transgene expression level using quantitative PCR on eye-
cup samples. In the LV-V65-treated group, the level of V65
expression correlated significantly with a- and b-wave
maximal amplitudes (Figures 5d and e). In the LV-GFP
control group, there was no correlation between transgene
expression level and ERG amplitudes. This result confirms
that blocking RPE hyperpermeability by V65 gene transfer
markedly protected photoreceptor function, although the
vector itself may have some unspecific effect. To analyze
whether this trophic effect observed at the functional level
reflected a better survival of photoreceptors, we treated
another series of animals with the same protocol and
assessed photoreceptor survival by the measurement of
ONL thickness. In accordance with ERG results, we
observed a massive thinning of the ONL in control groups.
Photoreceptor loss was negligible in the LV-V65-treated
group, whereas animals treated with the control vector
showed an intermediate loss (Supplementary Figure S3).
Interestingly, photoreceptor protection after V65 gene trans-
fer was homogenous across the dorsoventral axis of the
retina, suggesting that diffusion of the V65 protein brought its
trophic effect outside the transduced area of the retina
(Supplementary Figure S3).
We further characterized the morphology of rod and cone
OS using Peripherin–RDS and SWL–opsin as markers
(Figure 6). In sham-treated animals or in animals that
received no treatment prior to LD, both markers were totally
abolished, reflecting the dramatic photoreceptor degeneration
(Figures 6b, c, g and h). In LV-GFP-treated animals,
Peripherin–RDS staining was still present but OS appeared
shorter in length and disorganized (Figure 6d), whereas the
expression in LV-V65-treated animals OS appeared well
organized and with appropriate length (Figure 6e) compared
with the unlesioned retinas (Figure 6a). Similar results were
found for the cone OS marker SWL–opsin except that in the
LV-GFP group, in addition to a weaker expression level
compared with the unlesioned animals and LV-V65-treated
animals, the protein was partly mislocalized to the axon and
cone pedicle (Figures 6f–j).
To demonstrate that not only photoreceptors were
protected by V65 gene transfer but also that the retinal
circuitry was preserved and was able to convey an
interpretable signal to the brain, we studied the optokinetic
reflex (OR) in the different groups. This test is able to
discriminate rod and cone functions.38 In the case of the
Balb/c used in the present study, the scotopic OR
was significantly higher than the photopic one
(Supplementary Figure S4). We thus measured the scotopic
OR in the different groups before gene transfer and light
exposure, 2 weeks after gene transfer to evaluate the effect
of the subretinal injection on OR, and 10 days after LD to
assess the effect of light exposure. In all the control groups
(control vector-treated animals, sham-treated animals
or animals that received no treatment prior to LD), we
detected a drop in OR performance after LD corresponding
to the photoreceptor cell death (Figures 7a–c). On the
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contrary, OR performance was preserved after LD in the
LV-V65-treated group (Figure 7d), demonstrating that the retinal
circuitry mediating OR response was fully functional in this
group.
Discussion
We demonstrated that transient stress of the RPE might
have irreversible consequences on photoreceptor integrity
Figure 4 Blocking VEGF in the LD model inhibits RPE permeability and extravascular albumin leakage. The left panel shows the expression of beta-catenin stained on
flat-mounted RPE and analyzed on control unexposed to light (a) or 24 h after LD in the following groups: no treatment prior to LD (b), Sham- (c), LV-GFP- (d) and LV-V65-
treated animals (e and f). In unexposed control, the interface of cells is clearly delineated by beta-catenin staining (white arrowheads in a). In the control groups (no treatment
prior to LD, sham- and LV-GFP-injected), beta-catenin staining shows a clear translocation of the adherens-junction component toward the cytoplasm of RPE cells and is
absent at the cell contacts. Contrariwise, in the LV-V65-treated group, beta-catenin staining is maintained at the interface of cells (white arrowheads in e and f), although
slightly more diffuse than in absence of exposure to light. Note that GFP expression of LV-GFP (g) and LV-V65 (h) vectors are observed at the RPE level (n¼ 5 per group –
magnification  400 (confocal analysis) – red: beta-catenin and green: GFP). The right panel presents serum albumin staining of mice unexposed to light (i and j), untreated
before LD (k and l), Sham- (m and n), LV-GFP- (o and p) and LV-V65 (q and r)-treated groups and analyzed 10 days after LD. Plasma leakage is observed in Sham- and LV-
GFP-injected groups. Albumin positivity is evident in the choriocapillaris, RPE, ONL, OPL, INL, IPL and GCL. However, in the LV-V65-treated group, albumin staining is only
limited to the outer segments of the photoreceptors, which appeared to be protected by the blockade of VEGF (n¼ 8 per group – magnification  400, scale bar: 100 mm –
red: albumin and blue: Dapi, OS: outer segments, ONL: outer nuclear layer, INL: inner nuclear layer)
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and survival. Indeed, exposure to intense visible light triggers
outer BRB breakdown by activation of VEGF signaling. The
resulting hyperpermeability appears to be involved in light-
induced photoreceptor apoptosis. Moreover, outer BRB
breakdown and subsequently photoreceptor apoptosis can
be prevented by VEGF inhibition.
During the course of light damage, VEGF level is down-
regulated in the eye-cup (RPE, choroid) and upregulated in
the neural retina, indicating a loss of polarity of trophic factor
secretion by RPE cells after LD (Figure 2). This reversion of
VEGF distribution is associated with activation of the VEGFR-
2/Src pathway in the eye-cup presumably at the apical side of
the RPE (Figure 3), showing an abnormal polarity of VEGF
diffusion. As a consequence, there is a hyperpermeability of
RPE cells and a subsequent major contribution to the
degeneration of photoreceptors. In line with our results,
isolated human RPE cells have recently been shown to
respond to white light by increased expression and secretion
of VEGF. The effect of light could be inhibited by interference
with VEGF-R signaling.39 Another recently published article
showed that basolateral VEGF secretion from RPE cells is
indirectly triggered by light through phagocytosis of the shed
OS. Contrariwise to the experiments described here, the light
stimulus used by Ueta et al.40 remained in a physiological
range – that is, 5–15 lux on pigmented mice – probably
explaining the fact that they observe VEGF secretion at the
basolateral side only. In our case, the system might be
overwhelmed because of toxic light stimulation – 5000 lux in
albino mice – leading to VEGF secretion at the apical side.
We demonstrate that the toxicity of VEGF on photoreceptors
is not a direct action on these cells but rather secondary to
VEGF-induced RPE permeability. This rupture of the epithe-
lium integrity likely leads to changes of metabolite exchange
between the retina and the choroid that may further
destabilize photoreceptors after exposure to high levels of
light. Indeed, a massive influx of O2 and nutrients through
over-permeability of the RPEmay increase oxidative stress in
photoreceptors and ultimately lead to neuronal death. This
can be paralleled to what occurs after ischemia/reperfusion
injury in other organs, which leads to a high level of oxidative
stress and subsequent cellular damages as shown, for
example, in the liver41 or in the kidney.42 Another possibility
Figure 5 Blocking VEGF in the LD model is neuroprotective for photoreceptors. (a) Representative scotopic electroretinogram response for both the a- and b-wave
amplitudes. The quantification of the a-wave (b) amplitude at the different stimuli intensities reveals that response of the LV-V65-treated group is intermediate between control
unexposed to light and LV-GFP-treated mice responses. Note that LV-V65-treated mice response is significantly higher than LV-GFP-treated mice response for the following
intensities: 3 103 (Po0.05), 10 103 (Po0.01) and 25 103 (Po0.05) mcds/m2. Similarly, the quantification of the b-wave amplitude at the different intensities stimuli
showed the same result (c). LV-V65-treated mice response was significantly higher compared with LV-GFP-treated mice response for the same intensities: 3 103 (Po0.01),
10 103 (Po0.05) and 25 103 (Po0.05) mcds/m2. Results are expressed as mean±S.E. (n¼ 8 per group); statistical analyses: two-way ANOVA and Bonferroni’s post
hoc test. This experiment was reproduced with different batches of lentiviral vectors and led to the same results. Transgene expression level quantified by quantitative PCR
revealed that functional rescue of photoreceptor correlates with the level of V65 expression for both the a-wave (d) and the b-wave (e) maximal amplitudes (n¼ 10 per group)
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Figure 6 Blocking VEGF in the LD model preserved the rod and cone outer segment morphology. Peripherin–RDS expression, normally localized in rod and cone OS of
control unexposed to light (a), is completely abolished 10 days after light exposure (b). Peripherin–RDS expression is also absent in the sham-treated retina (c). Although
Peripherin–RDS staining is observed in both LV-GFP- (d) and LV-V65 (e)-treated retinas, the OS in the LV-GFP-treated group appeared shorter and disorganized compared
with those of LV-V65-treated group. In the LV-V65-treated group, the OS remains well organized and has an appropriate length. Similar result was obtained for the cone OS
marker SWL–opsin analyzed 10 days after LD. SWL–opsin staining, normally found in the cone OS of control unexposed to light (f and f0), is completely abolished after light
exposure (g and g0). Similarly, the expression of SWL–opsin is absent in sham-treated retina (h and h0). SWL–opsin expression is maintained in LV-GFP- (i and i0) and
LV-V65(j and j0)-treated groups; however, in addition to a weaker expression in the LV-GFP-treated group, the protein was partly mislocalized to the axon and cone pedicle
(i0) (n¼ 8 per group – magnification  400, scale bar: 100mm – red: Peripherin/SWL–opsin and blue: Dapi)
Figure 7 Blocking VEGF in the LD model preserved visual acuity. The optokinetic response (OR) was quantified in the following experimental groups: no treatment prior to
LD (a), Sham- (b), LV-GFP- (c) and LV-V65 (d)-treated groups. The quantification of the OR was measured at the beginning of the experiment (prior the injection and LD),
2 weeks after subretinal injection and 10 days after LD. Statistical analysis presented in the figures compared OR before and after light exposures. Results show that the
subretinal injection did not affect OR in the different injected groups (b–d), except in the LV-V65-treated group for 0.075 cpd. Contrariwise, 10 days after light exposure, ORs
recorded in the control groups (no treatment prior to LD and Sham-injected) were significantly impaired and no difference was observed compared with background value. OR
was still present but decreased in the LV-GFP-treated group after LD. Blocking VEGF preserved OR after light exposure in the LV-V65-treated group. Results are expressed
as mean±S.E. Statistical analyses: one-way ANOVA and Tukey’s post hoc test: n.s.: nonsignificant, *Po0.05, **Po0.01 and ***Po0.001 (n¼ 8 per group)
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strongly suggested by our observation is that, similarly to what
happens in different stroke models, direct contact between
plasmatic proteins and photoreceptors is detrimental to the
latter. Indeed, several publications have shown that the sole
presence of albumin is toxic for neurons.33,34 Finally, one can
also postulate that following direct damage induced by
exposure to toxic levels of white light, the RPE cells are no
longer able to ensure photoreceptor homeostasis.43,44 In the
present LD paradigm, the toxicity of VEGF is furthermore
reinforced by several parameters. Firstly, RPE permeability
might amplify VEGF leakage to the apical side of RPE cells by
the deregulation of VEGF secretion, as was shown recently by
Kunchithapautham and Rohrer45 on the RPE cell line ARPE-
19 exposed to sublytic levels of membrane-attack complex.
VEGF secretion at the apical side of RPE cells might thus be
auto-inducible, leading to a vicious cycle. Secondly, in our
model, PEDF is downregulated, thus making VEGF more
active for VEGFR-2, whose activation leads to RPE
permeability.9,30
In order to evaluate a possible direct VEGF action on
photoreceptor death, we measured phosphorylated p38,
which is known to trigger apoptosis in stressed cells,32 and
we found no differences between groups nor a potential
survival stimulation by VEGF through Akt phosphorylation,
suggesting that VEGF has no direct effect on photoreceptor
cells in this context. Several studies have revealed different
pathways, such as c-fos and AP-1, involved in photoreceptor
death.46,47 Interestingly, LD under high-light exposure does
not depend on transducin, whereas light toxicity through low-
light exposure requires transducin.48 It would be interesting to
study these different pathways when VEGF is inhibited to
understand how the indirect effect of the BRB breakdown
contributes to photoreceptor death. Indeed, an edema does
not usually produce a rapid degeneration of the photoreceptors,
suggesting that the light damage has severely affected the
survival/death balance of these cells and that RPE leakage
ultimately pushes the balance toward the death pathway. Such
study would help to better delineate the relative contribution of
the direct and the indirect inductions of cell death.
In our study, an acute strong stress produces a transient,
but deleterious, VEGF action, suggesting that in certain
diseases an acute stress can start to change RPE environ-
ment and then, on the long term, provide a toxic milieu. With
age, oxidative stress of photoreceptors brings deposits at the
level of Bruch’s membrane;12 deregulation of the complement
pathway leads to RPE dysfunction, at least in vitro,45 by
enhancing VEGF secretion; andmyeloid cells can enhance, in
certain cases, the side effects derived from this environ-
ment.49,50 It would be important to study the sequence of
these events in regards to RPE dysfunction to identify the key
factors before a vicious cycle that maintains elevated VEGF
levels is established.
Anti-VEGF treatment is currently and efficiently used to
treat vascular permeability in wet-AMD51 and to decrease
subretinal edema.52,53 This recovery was often mainly
attributed to the vascular effect of the anti-VEGF treatment.
However, in view of our results, we cannot exclude that in
certain cases, the amelioration may also be because of a
re-establishment of the RPE integrity preventing inward fluid
flux from the choroid. A similar statement can be hypothesized
for macular edema occurring during diabetic retinopathy
depending on VEGF levels and distribution. Our results
strongly suggest that it is also important to investigate RPE
integrity in these diseases to ameliorate diagnosis and
therapeutic intervention.
Materials and Methods
Animals. Animals were handled in accordance with the ‘Animals in Research
Committee’ statement of the Association for Research in Vision and
Ophthalmology (Rockville, MD, USA) and approved protocols of the local
institutional committee (Office des Affaires Ve´te´rinaires du Canton de Vaud,
Lausanne, Switzerland). Mice were housed in communal cages (five to six animals
per cage), maintained in controlled temperature (22 1C) and light (12 h light–dark
cycle) and fed ad libitum. This work included wild-type C57/Bl6 mice (provided by
Charles River, Lyon, France) and Balb/c mice (provided by Harlan Laboratories
BV, Venray, Netherlands). All experiments were run with 8–12 weeks old male
mice.
Light damage and degeneration. Photic injury to mouse retinas was
carried out as described by Wenzel et al.54 Balb/c mice that display a susceptibility
to LD were kept for 4 weeks in cyclic light at or below 80 lux. Mice were
dark-adapted overnight (16 h) and then immediately exposed to 5000 lux of diffuse
white-fluorescent light (TLD36 W/965 tubes, Philips, Hamburg, Germany,
UV-impermeable diffuser) for 1 h in a cage with reflective interior. Fluorescent-
white light emitted from TLD36 W/965 tubes has an emission spectrum similar to
daylight to mimic excessive exposure (reviewed in Wenzel et al.13). After
exposure, mice returned to complete darkness until retinal morphology was
analyzed or until their eyes were prepared for western blotting (between 2 h and
10 days). Mice were then killed by cervical dislocation and decapitation under dim
red light conditions. To evaluate the degeneration, measures of the ONL thickness
were taken at 300 and 400mm dorsally and ventrally, respectively, from the optic
nerve head on cryosections, and data were pooled as a mean for each points to
evaluate degenerating central retina. The measures were taken using an Olympus
BX60 microscope equipped for epifluorescence (Olympus Suisse SA, Aigle,
Switzerland) coupled to the Cell-P software (Soft Imaging System, Olympus,
Hamburg, Germany).
Protein extraction and western blotting. Neural retinas and eye-cups
were collected in 200ml of homogenization buffer composed of 137 mM NaCl, 20 mM
Tris pH 8, 1% Nonidet-P40, 10% Glycerol, 2 mM EDTA, 1/100 phosphatase inhibitors
1 and 2 (Sigma, Steinlheim, Germany) and complete Mini ESTA-free anti-protease
(Roche Diagnostics, Indianapolis, IN, USA). The protein content was determined
using a Bradford assay (Bio-Rad Laboratories, Munich, Germany).
Western blotting: Proteins were loaded and separated using SDS-PAGE and
blotted onto PVDF membranes. After blocking in Tris-buffered saline containing
0.1% Tween-20 (TBS-T) and 5% dry-milk, membranes were incubated with
primary antibodies overnight at 4 1C in TBS-T containing 5% milk or 5% BSA.
Primary antibody providers and concentrations are described in Supplementary
Table 2. After incubation with the appropriate peroxydase-coupled secondary
antibodies in blocking buffer for 1 h, signal was revealed by a chemiluminescent
substrate (ECL plus western blotting detection system, GE Healthcare,
Buckinghamshire, UK), and then membranes were exposed to hyperfilm ECL
(Hyperfilmchemiluminescence film, GE Healthcare). Results were analyzed using
the ImageJ software (National Institutes of Health, Bethesda, MD, USA) to
determine relative expression.
VEGF content and cell-death quantification. VEGF content was
evaluated on neural retinas and eye-cups homogenized as previously mentioned.
VEGF ELISA was performed using the VEGF Quantikine Immunoassay (R&D
systems, Minneapolis, USA) following the manufacturer’s instructions. Cell death
was quantified on retinas collected 24, 36 and 48 h after LD using Cell Death
Detection Kit (Roche Diagnostics) according to the manufacturer’s recommenda-
tions. In this case, retinas were homogenized directly with CDD buffer included in
the kit. The timepoint chosen corresponds to the peak of apoptosis (reviewed in
Wenzel et al.13). Results were obtained using the Revelation software connected to
a plate reader MRXII (Dynex technologies, Chantilly, VA, USA).
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Lentiviral vectors and in vivo gene transfer. Lentiviral constructs,
generation of lentiviral particles and in vivo delivery are described in details in
Supplementary Methods. Briefly, lentiviral vectors used in this study are self-
inactivating, HIV-1-derived vectors. Lentiviral particles were produced by transient
co-transfection of 293T cells with a lentiviral shuttle plasmid, a packaging plasmid
and an expression plasmid encoding the heterologous envelope VSV-G. Lentiviral
particles were harvested 48 h after transfection in the cell supernatant,
concentrated by ultracentrifugation and measured by p24 ELISA. Adult mice
were treated by subretinal delivery of a vector dose corresponding to 150 ng of
p24 protein. LVs were injected in C57/Bl6 mice 5 days before laser injury and
subretinal injections were performed 3 or 4 weeks before LD in Balb/c mice.
Histology
Cryosections: eyes were enucleated immediately after killing of the animals
and fixed for 1 h in 4% paraformaldehyde (PFA) in phosphate-buffered saline
(PBS). After overnight incubation in 30% sucrose, the eyes were embedded in
albumin from hen egg white (Fluka, Buchs, Switzerland) and processed into
14-mm-thick cryosections.
RPE flat-mount preparations: Enucleated eyes were immediately fixed in
4% PFA for 20 min and transferred to PBS. The eyes were sectioned at the
equator, and the anterior half including the lens and the vitreous bodies were
discarded. Neural retinas were carefully peeled from the eye-cup. The posterior
part containing the RPE and choroid was dissected into quarters by four radial
cuts and conserved in PBS at 4 1C until subsequent use.
Immunolabelling: Immunohistochemistry on cryosections was performed as
described previously.38,55 Briefly, the first antibody was incubated overnight at 4 1C
in PBS containing 0.2% Triton X-100 and 10% normal goat serum (NGS)
(Dako, Zug, Switzerland). Primary antibody providers and concentrations are
described in Supplementary Table 1. When antibodies were not preconjugated
directly with the fluorochrome, revelation was carried out with the appropriate
Alexa-633 (Molecular Probes, Eugene, OR, USA) or Alexa-488 (Molecular
Probes)-coupled secondary antibody and incubated 1 h at 37 1C. After incubation,
slides were washed three times in PBS. Nuclei were counterstained with
4,6-diamidino-2-phenyindole (DAPI) (Molecular Probes) and mounted under
coverslips with Mowiol 4-88 Reagent (VWR International AG, Lucerne, Switzerland).
Staining was analyzed using a BX60 microscope equipped for epifluorescence
and Cell-P software or using a confocal microscope Leica SP5 AOBS
(Leica Microsystems CMS, Mannheim, Germany) using the Leica application
suite (ALS) software. For immunolabelling on RPE flat mounts, the blocking
solution was composed of PBS with 10% NGS and 1% Triton X-100. Primary
antibody was diluted in the blocking solution and incubated overnight at 4 1C.
Primary antibody providers and antibody concentrations are described in
Supplementary Table 1. Detection of primary antibodies was carried out with
Alexa-633- Alexa-488- or Cy3-coupled secondary antibodies diluted in PBS with
10% NGS and 0.1% Triton X-100 and incubated 1 h at RT. Flat mounts were
mounted as cryosections. Staining was analyzed using a Leica SP5 AOBS
confocal microscope and ALS software. TUNEL Staining was performed with the
Dead End Colorimetric TUNEL System Kit (Promega, Madison, WI, USA).
Electroretinograms. ERG recordings were performed as previously
described.55 After dark adaptation mice were anesthetized with ketamine
(100 mg/kg) and xylazine (15 mg/kg), and pupils were dilated by 0.5% tropicamid
(Novartis Pharma, Bern, Switzerland). The mouse was placed in the Ganzfeld
stimulator of a Multiliner Vision apparatus (Jaeger/Toennies, Ho¨chberg, Germany).
The corneal ERG was then recorded under scotopic conditions in response to
single flashes of white light ranging from 1 10 4 to 25 candelas cd s m 2.
Optokinetic Reflex. The experimental setup and the procedure were
previously described in details.38 Briefly, Balb/c mice were tested in an optokinetic
drum with spatial frequencies increasing from 0.025 to 0.1 cycles per degree (cpd),
starting with scotopic condition (dim-light inferior to 0.01 lux), followed by photopic
condition (650 lux). During each session, the drum rotated alternatively clockwise
and anticlockwise, by inverting the rotation direction at mid-session, and behavior
was recorded using a camcorder enabling infrared recording in scotopic conditions
(Sony CDR-HC90E). Head movements were then scored: clockwise movement
drives tracking through the left eye, whereas counterclockwise motion activates
the right eye.56 A movement was counted when the animal followed the drum
rotation at the same angular speed and in the same direction for a minimum of
151. A level of Po0.05 (two-tailed) was considered significant. The OR of Balb/c
mice not exposed to LD was first evaluated in both photopic and scotopic
conditions. Then, the OR response was evaluated in Balb/c mice submitted to LD.
In this case, the OR was only analyzed under scotopic conditions at three different
time points: at the beginning of the experiment, after the subretinal injections
(LV-GFP, LV-V65 or Sham) in order to evaluate the effect of the injection and
finally, 10 days after LD.
Statistical analysis. All data were analyzed using Prism 5.0 Software
(GraphPad Software Inc., San Diego, CA, USA). The different statistical analyses
are mentioned in each figure legend. A level of Po0.05 (two-tailed) was
considered significant.
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